AbstractHIVFecal Proteobacteria Positively Correlates with The Activation of Circulating ISGs and CD4+ T Cells in Vesatolimod-treated HIV Controllers on ARTView Abstract
AbstractHIVIntestinal microbial communities and the intestinal microbe Holdemanella biformis isolated from HIV+/- men who have sex with men increase CCR5 expression on intestinal CD4 T cellsView Abstract
AbstractHIVChanges in Gut Microbiome in HIV-Infected Individuals Undergoing Long Term Antiretroviral Therapy Receiving Rifaximin: Results of the GUTCHEK StudyView Abstract
AbstractHIVAlterations in the Gut Microbiome of HIV infected patients under Antiretroviral TherapyView Abstract
AbstractHIVHIV Replication, Transmission, and the Metabolome of the Female Reproductive TractView Abstract
AbstractHIVLactic acid produced by an optimal vaginal microbiota promotes cervicovaginal epithelial barrier integrity: implications for HIV transmissionView Abstract
AbstractHIVBaseline gut-associated microbial signatures may help predict HIV-1 viral control after treatment interruptionView Abstract
AbstractHIVGut microbial regulation of anxiety disorder in a murine model of HIV-1 and opioid abuseView Abstract
AbstractHIVMosquito borne parasites in patients newly infected with HIV in relationship with CD4 count and TNFαView Abstract
AbstractHIVBaseline gut microbiome dysbiosis predicts gut microbiome response to ART/co-trimoxazole treatment in HIV-positive individuals in rural and urban ZimbabweView Abstract
AbstractHIVAlteration of the gut fecal microbiome in HIV infected children on anti-retroviral therapy in Yaounde, CameroonView Abstract
AbstractHIVA FAST FORWARD INVESTIGATIVE FORECASTING: Challenges, Unmet Needs and Gaps of the New HIV Prevention Technologies (NPT) in a Malawian ContextView Abstract
AbstractHIVComparative analysis of vaginal microbiota sampling using the menstrual cups and high vaginal swabs in HIV-1 infected pregnant womenView Abstract
